PKBDO6229UTLA
PKBDO6229UTLA
released
Clinical summary
Diabetes status
Type 2 Diabetes
Age (y)
59
Age group
40-64
BMI
32.23
Height (cm)
—
Weight (kg)
—
HbA1c %
8.7
C-Peptide (ng/ml)
1.52
Diabetes duration
3
AAB summary
GADA+
AAB count
1
Demographics
- Age (y)
- 59
- Age group
- 40-64
- Pediatric
- No
- Gender
- Female
- Genetic Sex
- Female
- Sex discordant
- No
- Ethnicity
- White
- Predicted genetic ancestry
- European (98%), Admixed-American (2%)
- Dominant genetic ancestry
- European
Additional clinical
- Diabetes (ontology)
- T1D stage
- Conflicting diabetes evidence
- HbA1c-derived diabetes status
- Diabetes
- Label vs HbA1c discordant
- No
- Tier 1 complete
- Yes
- Family history of diabetes
- FALSE
- Living donor
- No
- Cause of death
- Cerebrovascular/Stroke
- Donation type
- Donation after brain death
- Hospital stay (h)
- 42
- Medication
- Metformin,Glipizide
Autoantibodies
- Summary
- GADA+
- Any positive
- Yes
- Tested
- Yes
- Positive count
- 1
GADAPositive
24 unit/ml
1
IAANegative
-0.004 unit/ml
IA2Negative
0 unit/ml
ZNT8Negative
-0.002 unit/ml
HLA typing
Status: X/DR3
| Locus | Allele 1 | Allele 2 | Method |
|---|---|---|---|
| A | 1 | 2 | RT-PCR |
| B | 8 | 13 | RT-PCR |
| Bw4 | 1 | 1 | RT-PCR |
| Bw6 | 1 | 1 | RT-PCR |
| C | 06 | 07 | RT-PCR |
| DPB1 | 04:01 | 04:02 | RT-PCR |
| DQA1 | 01:02 | 05:01 | RT-PCR |
| DQB1 | 2 | 6 | RT-PCR |
| DR | 17 | 15 | RT-PCR |
| DR51 | 51 | 0 | RT-PCR |
| DR52 | 52 | 0 | RT-PCR |
| DR53 | 0 | 0 | RT-PCR |
Data available
- Datasets
- Genotyping, HLA_typing, RNAseq, scRNAseq, Function, Imaging, Histology, CODEX
- Tissues
- unspecified, Islet, Pancreas, Spleen, Lymph
Genetics
GenotypingAccess dataset
HLA_typingAccess dataset
Islet
Pancreas
histologyAccess dataset
CODEXAccess dataset
Spleen
histologyAccess dataset
Lymph
histologyAccess dataset
Supplementary
HPAP
PANC-DB:HPAP-090
- Pancreas tissue available
- Yes
- Other tissues
External resources
PANC-DB:HPAP-090
Attribution
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
